The Khao Kheow Open Zoo was overrun with Moo Deng fans on the first of four days of activities marking the birthday of the adorable social media sensation.

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

The Trump Administration's financial cuts to global development programs pose a challenge for organizations fighting deadly infectious diseases both in the U.S. and abroad.

According to the American Psychiatric Association, more than 30% of Americans say their sleep quality is poor or they aren’t getting enough sleep each night.

A recent study shows that top scavengers, like hyenas, can be beneficial for human health. But the same study reveals that scavenger populations are declining and could mean more disease for humans.

The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.

During the COVID-19 pandemic, skepticism of science and medicine broke down along partisan lines.

Rural hospitals that are dependent on Medicaid funding can tap into a $50 billion fund in President Trump's new tax cut and spending law, which cut Medicaid spending overall.

The U.S. has hit an unwelcome milestone in measles cases this year. The CDC is reporting 1,288 cases across the country. The disease was declared eliminated 25 years ago.

Europe recently downgraded the protected status of wolves, sparking concern among conservationists who warn this may undo decades of progress and lead to the species becoming threatened again.